MedPath

The evaluation test of glucose tolerance change and intestinal environmental change by intake of barley

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000023675
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

1)Subjects who didn't undergo abdominal surgical operation within 6 month before test start. 2)Subjects who didn't take antibiotics for 1 month or more within 6 month before test start. 3)Subjects who have allergy to test food. 4)Smokers 5)Subjects whose consort or partner also participates to same clinical test. 6)Subjects who plan big change of lifestyle during test period. 7)Subjects with tendency of chronic diarrhea. 8)Subjects who considered unfitness for the test because of having previous and/or current medical history of serious disease of liver, kidney and heart. 9)Subjects who suspected chronic or serious infectious disease. 10)Premenopausal women. 11)Subjects who participated the other clinical test within 1 month before test start. 12)Subjects who donated over 200 mL blood and/or blood components within the last one month to the current study. 13)Males who donated over 400 mL blood within the last three month to the current study. 14)Females who donated over 400 mL blood within the last four month to the current study. 15) Males who will be collected over 1200 mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 16) Females who will be collected over 800 mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 17)Others who have been determined ineligible by principal investigator or sub-investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the curve of blood glucose and blood insulin in glucose tolerance test during 2weeks and 4 weeks of consumption
Secondary Outcome Measures
NameTimeMethod
1)Incremental area under the curve of blood glucose and blood insulin in glucose tolerance test during 2weeks and 4 weeks of consumption 2)Blood glucose and blood insulin in glucose tolerance test during 2weeks and 4 weeks of consumption 3)Improving effect of intestinal environment (bowel movement, intestinal microflora, intestinal metabolite) during 2weeks and 4 weeks of consumption 4)Questionnaire of physical feeling during 2weeks and 4 weeks of consumption
© Copyright 2025. All Rights Reserved by MedPath